EUCAPA

EUCAPA – European Capacity Building for Patients

The European Regulation on health technology assessment 2021/2282 (HTA Regulation) entered into force in January 2022 and applies as of January 2025. With the new HTA regulation, the importance of the patient perspective increases. Patient experts will participate in two main areas: the joint clinical assessments for medicines and medical devices and joint scientific consultations.

EUCAPA will build the skills and knowledge of patient advocates who will participate in HTAs. It will also prepare patient organisations to respond to the requests for patient experts from European HTA Cooperation.

After undergoing the training programmes, participants will:

• have the capacity of understanding HTA goals, methods and processes, especially those developed by EUnetHTA21 for implementing the European HTA regulation.
• be able to apply their knowledge of the HTA process.
• have the skills enabling competent participation in joint scientific consultations and joint clinical assessments.
• be able to critically appraise HTA reports and communicate their results and conclusions.

be able to actively discuss the different stakeholder positions.